BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 24009001)

  • 1. Noninvasive prenatal testing: limitations and unanswered questions.
    Lutgendorf MA; Stoll KA; Knutzen DM; Foglia LM
    Genet Med; 2014 Apr; 16(4):281-5. PubMed ID: 24009001
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prenatal screening for fetal aneuploidy in singleton pregnancies.
    Chitayat D; Langlois S; Douglas Wilson R; ;
    J Obstet Gynaecol Can; 2011 Jul; 33(7):736-750. PubMed ID: 21749752
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Noninvasive prenatal testing for fetal aneuploidy: clinical assessment and a plea for restraint.
    Norton ME; Rose NC; Benn P
    Obstet Gynecol; 2013 Apr; 121(4):847-850. PubMed ID: 23635685
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Noninvasive prenatal testing in routine clinical practice for a high-risk population: Experience from a center.
    Qi G; Yi J; Han B; Liu H; Guo W; Shi C; Yin L
    Medicine (Baltimore); 2016 Oct; 95(41):e5126. PubMed ID: 27741136
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prospective observations study protocol to investigate cost-effectiveness of various prenatal test strategies after the introduction of noninvasive prenatal testing.
    Kim SY; Lee SM; Jun JK; Han YJ; Kim MH; Shim JY; Lee MY; Oh SY; Lee J; Kim SH; Cha DH; Cho GJ; Kwon HS; Kim BJ; Park MH; Cho HY; Ko HS; Ahn J; Ryu HM
    BMC Pregnancy Childbirth; 2018 Jul; 18(1):307. PubMed ID: 30041617
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prenatal screening for fetal aneuploidies with cell-free DNA in the general pregnancy population: a cost-effectiveness analysis.
    Fairbrother G; Burigo J; Sharon T; Song K
    J Matern Fetal Neonatal Med; 2016; 29(7):1160-4. PubMed ID: 26000626
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Screening for Fetal Chromosomal Abnormalities: ACOG Practice Bulletin Summary, Number 226.
    Obstet Gynecol; 2020 Oct; 136(4):859-867. PubMed ID: 32976375
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stepwise sequential screening for fetal aneuploidy.
    Benn PA; Campbell WA; Zelop CM; Ingardia C; Egan JF
    Am J Obstet Gynecol; 2007 Sep; 197(3):312.e1-5. PubMed ID: 17826434
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Noninvasive prenatal testing for fetal aneuploidy and single gene disorders.
    Skrzypek H; Hui L
    Best Pract Res Clin Obstet Gynaecol; 2017 Jul; 42():26-38. PubMed ID: 28342726
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Screening for Fetal Chromosomal Abnormalities: ACOG Practice Bulletin, Number 226.
    ; ;
    Obstet Gynecol; 2020 Oct; 136(4):e48-e69. PubMed ID: 32804883
    [TBL] [Abstract][Full Text] [Related]  

  • 11. First trimester ultrasound screening for fetal aneuploidy and middle cerebral artery Doppler assessment for fetal alloimmunization.
    Biggio JR
    Curr Opin Pediatr; 2005 Dec; 17(6):713-9. PubMed ID: 16282776
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prenatal Diagnosis Innovation: Genome Sequencing of Maternal Plasma.
    Wong FC; Lo YM
    Annu Rev Med; 2016; 67():419-32. PubMed ID: 26473414
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Integration of Noninvasive Prenatal Screening into the Existing Prenatal Paradigm: a Survey of Current Genetic Counseling Practice.
    Suskin E; Hercher L; Aaron KE; Bajaj K
    J Genet Couns; 2016 Oct; 25(5):1032-43. PubMed ID: 26879922
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prenatal screening for and diagnosis of aneuploidy in twin pregnancies.
    Audibert F; Gagnon A; ;
    J Obstet Gynaecol Can; 2011 Jul; 33(7):754-67. PubMed ID: 21749753
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Committee Opinion No. 640: Cell-Free DNA Screening For Fetal Aneuploidy.
    Obstet Gynecol; 2015 Sep; 126(3):e31-e37. PubMed ID: 26287791
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Committee Opinion Summary No. 640: Cell-Free DNA Screening For Fetal Aneuploidy.
    Obstet Gynecol; 2015 Sep; 126(3):691-692. PubMed ID: 26287784
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A two-year experience of non-invasive prenatal testing (NIPT) at an urban tertiary medical center in South Korea.
    Noh JJ; Ryu HM; Oh SY; Choi SJ; Roh CR; Kim JH
    Taiwan J Obstet Gynecol; 2019 Jul; 58(4):545-551. PubMed ID: 31307749
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Performance of semiconductor sequencing platform for non-invasive prenatal genetic screening for fetal aneuploidy: results from a multicenter prospective cohort study in a clinical setting.
    El Khattabi LA; Brun S; Gueguen P; Chatron N; Guichoux E; Schutz S; Nectoux J; Sorlin A; Quere M; Boudjarane J; Tsatsaris V; Mandelbrot L; Schluth-Bolard C; Dupont JM; Rooryck C;
    Ultrasound Obstet Gynecol; 2019 Aug; 54(2):246-254. PubMed ID: 30191619
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical Practice Guidelines for Prenatal Aneuploidy Screening and Diagnostic Testing from Korean Society of Maternal-Fetal Medicine: (1) Prenatal Aneuploidy Screening.
    Choe SA; Seol HJ; Kwon JY; Park CW; Kim M; Lee JY; Kim MA; Hwang HS; Na S; Shim JY; Kim K; Ryu HM
    J Korean Med Sci; 2021 Jan; 36(4):e27. PubMed ID: 33496086
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of a DNA method, QF-PCR, in the prenatal diagnosis of fetal aneuploidies.
    Langlois S; Duncan A; ;
    J Obstet Gynaecol Can; 2011 Sep; 33(9):955-960. PubMed ID: 21923994
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.